Mucin-like carcinoma-associated antigen (MCA)
Mucin-like carcinoma-associated antigen (MCA)
The indications of mucin-like carcinoma-associated antigen (MCA) test is the monitoring of flow and detection of recurrence of breast carcinoma. Mucin-like carcinoma-associated antigen (MCA) is a mucin-glycoprotein with a molecular mass 350-500 kDa.
Normal value of mucin-like carcinoma-associated antigen (MCA) — 11 IU/ml.
Elevated levels of mucin-like carcinoma-associated antigen (MCA) is observed in the serum of patients with breast cancer. This increase often correlates with the stage of disease. Elevated levels of mucin-like carcinoma-associated antigen (MCA) is recorded in pregnant women (from 4 month) and in 20% of cases of benign liver diseases and mastopathy.
It is not advisable combined use mucin-like carcinoma-associated antigen (MCA) test and CA 15-3 or CA 549 tests, since in this case the diagnostic sensitivity is not increased. In order to increase the sensitivity desired combination with carcinoembryonic antigen (CEA).
See also
- Complete blood count (CBC):
- Urinalysis:
- Cerebrospinal fluid (CSF) analysis
- Biochemical markers of bone remodeling and diseases
- Markers of autoimmune connective tissue diseases (CTDs)
- Antiphospholipid syndrome (APS)
- Lipoprotein(a), Lp(a)
- Semen analysis (sperm count test)
- Tumor markers tests (cancer biomarkers):
- β-2 microglobulin (beta-2)
- Alpha-fetoprotein (AFP)
- Squamous cell carcinoma antigen (SCC)
- S100 protein tumormarker
- Calcitonin
- Mucin-like carcinoma-associated antigen (MCA)
- Neuron-specific enolase (NSE)
- Prostate-specific antigen (PSA) test
- Cancer associated antigen 549 (CA 549)
- CA 19-9, CA 72-4, CA 50, CA 15-3 and CA 125 tumor markers (cancer antigens)
- Carcinoembryonic antigen (CEA)
- Thyroglobulin (Tg)
- Tissue polypeptide antigens (ТРА, TPS)
- Cytokeratin-19 fragment (CYFRA 21-1)
- Human chorionic gonadotrophin (hCG)
